Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ARB202 |
Trade Name | |
Synonyms | ARB-202|ARB 202 |
Drug Descriptions |
ARB202 is a bi-specific T-cell engager (BiTE) antibody that targets CDH17 and CD3, potentially leading to CDH17-dependent tumor cell killing and inhibition of tumor growth (J Clin Oncol 39, no. 3_suppl (January 20, 2021) 405). |
DrugClasses | CD3 Antibody 99 |
CAS Registry Number | NA |
NCIT ID | C188232 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ARB202 | ARB202 | 0 | 1 |
ARB202 + Atezolizumab | ARB202 Atezolizumab | 0 | 1 |